Matthew W Foehr
President and CEO, Director, OmniAb, Inc.; Director, Viking Therapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$0.7M
Companies
2
Latest trade
Apr 7, 2026
Companies
OmniAb, Inc.President and CEO, Director −$0.1M Viking Therapeutics, Inc.Director −$0.6MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

